Bank Of Nova Scotia Atossa Therapeutics, Inc. Transaction History

Bank Of Nova Scotia

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.6 - $3.27 $243,384 - $497,416	-152,115 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$2.89 - $6.4 $568,124 - $1.26 Million	-196,583 Reduced 56.38%	152,115 $495,000
Q2 2021 Aug 12, 2021	BUY	$1.52 - $8.62 $530,020 - $3.01 Million	348,698 New	348,698 $2.2 Million

25.8M

404K

83.6K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $191M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.